To explore the aetiology of pathological laughing, a 65-year-old woman with pathological laughing was examined by 3-T functional magnetic resonance imaging (fMRI) before and after treatment with drugs. Here, we report that the patient consistently showed exaggerated pontine activation during the performance of three tasks before treatment, whereas abnormal pontine activation was no longer found after successful treatment with the selective serotonin reuptake inhibitor, paroxetine. Our findings in this first fMRI study of pathological laughing suggest that serotonergic replacement decreases the aberrant activity in a circuit that involves the pons.
- EPI, echo planar imaging
- fMRI, functional magnetic resonance imaging
- PLC, pathological laughing and crying
- SSRI, selective serotonin reuptake inhibitor
- TR/TE, repetition time or echo time
Statistics from Altmetric.com
Competing interests: None declared.
The protocol was approved by the Ethical Committee of University of Fukui and the patient gave written informed consent for the study.
Consent was obtained for publication of the patient’s details described in this report.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.